Futura Medical (FUM) Competitors GBX 5.76 -3.07 (-34.77%) As of 09/19/2025 11:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock FUM vs. TILS, VSN, MPH, SCLP, ORPH, HVO, REDX, IMM, ETX, and SBTXShould you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Tiziana Life Sciences (TILS), Verseon (VSN), Mereo BioPharma Group plc (MPH.L) (MPH), Scancell (SCLP), Open Orphan (ORPH), hVIVO (HVO), Redx Pharma (REDX), ImmuPharma (IMM), e-therapeutics (ETX), and SkinBioTherapeutics (SBTX). These companies are all part of the "biotechnology" industry. Futura Medical vs. Its Competitors Tiziana Life Sciences Verseon Mereo BioPharma Group plc (MPH.L) Scancell Open Orphan hVIVO Redx Pharma ImmuPharma e-therapeutics SkinBioTherapeutics Futura Medical (LON:FUM) and Tiziana Life Sciences (LON:TILS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings. Does the media favor FUM or TILS? In the previous week, Futura Medical's average media sentiment score of 0.00 equaled Tiziana Life Sciences'average media sentiment score. Company Overall Sentiment Futura Medical Neutral Tiziana Life Sciences Neutral Which has preferable valuation & earnings, FUM or TILS? Tiziana Life Sciences has lower revenue, but higher earnings than Futura Medical. Tiziana Life Sciences is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFutura Medical£13.93M1.26-£3.88M£0.001,404.88Tiziana Life Sciences-£3.60M0.00N/A-£16.30N/A Is FUM or TILS more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to Futura Medical's net margin of -44.64%. Tiziana Life Sciences' return on equity of 0.00% beat Futura Medical's return on equity.Company Net Margins Return on Equity Return on Assets Futura Medical-44.64% -56.44% -26.59% Tiziana Life Sciences N/A N/A N/A Do insiders & institutionals believe in FUM or TILS? 0.0% of Futura Medical shares are held by institutional investors. 1.5% of Futura Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryFutura Medical beats Tiziana Life Sciences on 5 of the 8 factors compared between the two stocks. Get Futura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FUM vs. The Competition Export to ExcelMetricFutura MedicalBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£26.55M£149.56M£5.79B£2.55BDividend Yield4.55%3.78%5.63%5.31%P/E Ratio1,404.8835.8376.485,395.39Price / Sales1.264,679.90531.7297,580.94Price / Cash20.4313.1937.9227.93Price / Book2.22135.1313.729.20Net Income-£3.88M-£90.99M£3.29B£5.89B7 Day Performance-34.11%0.23%2.66%0.68%1 Month Performance-36.56%20.09%6.02%3.40%1 Year Performance-83.96%785.19%80.02%195.42% Futura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FUMFutura MedicalN/AGBX 5.76-34.8%N/A-84.0%£26.55M£13.93M1,404.8812Gap DownHigh Trading VolumeTILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911Positive NewsVSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownSCLPScancellN/AGBX 8.50-2.9%N/A-33.1%£88.21MN/A-408.6551Insider TradeORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179HVOhVIVO1.8102 of 5 starsGBX 9.12-6.9%GBX 28+207.0%-66.3%£62.67M£62.73M588.39N/AREDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeIMMImmuPharmaN/AGBX 10.80-2.9%N/A+631.0%£53.97MN/A-1,213.4813Trending NewsGap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035High Trading VolumeSBTXSkinBioTherapeuticsN/AGBX 15.50+3.3%N/A+56.2%£40.11M£2.68M-1,240.0011 Related Companies and Tools Related Companies TILS Alternatives VSN Alternatives MPH Alternatives SCLP Alternatives ORPH Alternatives HVO Alternatives REDX Alternatives IMM Alternatives ETX Alternatives SBTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FUM) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Futura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
